Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced that members of its executive team will participate in one-on-one investor meetings at the following conference:
D. Boral Capital Global Conference
- Date: May 7, 2026
- Location: New York, USA
| Press release in English | 139.38 KB |
| Communiqué de presse en français | 131.83 KB |